AstraZeneca
AZN
370 hedge funds and large institutions have $6.54B invested in AstraZeneca in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 124 increasing their positions, 133 reducing their positions, and 32 closing their positions.
39% more call options, than puts
Call options by funds: $92.4M | Put options by funds: $66.4M
4% more capital invested
Capital invested by funds: $6.27B → $6.54B (+$274M)
0.33% more ownership
Funds ownership: 7.8% → 8.13% (+0.33%)
3% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 32
7% less repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 133
1% less funds holding
Funds holding: 375 → 370 (-5)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$333M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$109M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.5M |
| 4 |
CI
Cambiar Investors
Denver,
Colorado
|
+$46.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$44.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$79.5M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$37.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$36M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$14.1M |
AZN Hedge Fund Activity: Q3 2015 in Review
370 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2015, worth a combined $6.54B — up 4.4% from $6.27B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of AZN and 31 opened new positions — a net loss of 1 holder — while 133 trimmed existing stakes and 124 added.
The largest buyer was Bank of America, adding an estimated $333M. The largest seller was Renaissance Technologies, cutting an estimated $79.5M.
- 370 institutional investors held AstraZeneca (AZN) as of Q3 2015, down from 375 in Q2 2015.
- Funds reported $6.54B of AstraZeneca stock for Q3 2015, up 4.4% quarter-over-quarter.
- 31 funds opened new AstraZeneca positions in Q3 2015 and 32 closed out, a net change of -1 holder.
- The largest AstraZeneca buyer in Q3 2015 was Bank of America, an estimated $333M added.
- The largest AstraZeneca seller in Q3 2015 was Renaissance Technologies, an estimated $79.5M sold.
Based on aggregated 13F filings for Q3 2015.